With long development timelines and high burn rates, biotech companies must navigate capital markets with precision.

Armis is stepping up its efforts to achieve readiness for an initial public offering and eyeing potential IPO timing as soon as the second half of 2024 , Co-Founder and CEO Yevgeny Dibrov told CRN ...

More importantly, the IPO brings Softchoice into the spotlight at a time when its cloud-focused services and software capabilities are in high demand ... So the timing just seemed right.

The company said it will look at a more “strategic timing” to launch the IPO. It had got approval to proceed with a public listing from Securities and Exchange Board of India (SEBI) ...

E-WALLET giant GCash is preparing for a potential initial public offering (IPO), but the timing remains uncertain due to market volatility caused by new US tariffs under President Donald J. Trump, ...